Delivery Order SPE2DB20D6037-SPE2DB25FTUS3
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$5.4K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,211.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, which is not associated with any set-aside designations, is for the provision of the pharmaceutical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" with a completion date of November 19, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $11,764.48, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML" and has a firm fixed price pricing type with a completion date of February 3, 2025. Additionally, DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,474.20 firm fixed-price delivery order is for the supply of a pharmaceutical product, specifically ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $5,896.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract covers the delivery of the pharmaceutical product Zepbound 5 mg/0.5 mL pen. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which enables the agency to issue delivery orders for a broad range of pharmaceutical...
This federal contract award, valued at $3,685.50, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order for the pharmaceutical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML." DMS Pharmaceutical Group holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC...
This federal contract award, identified as SPE2DB20D6037 and SPE2DB25FTUL1, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $8,388.38, is a firm fixed-price delivery order for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $8,873.25 and covers the delivery of ZEPBOUND 5 MG/0.5 ML PEN 0.25ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of January 8, 2025 and is not associated with any set-aside...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $3,685.50, is for the delivery of a specialty pharmaceutical product called ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. It is a part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at $499,999,999, which enables the DLA to issue delivery orders for a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,489.02 firm fixed-price delivery order contract is for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a specialized pharmaceutical product, to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,575.48 contract covers the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, a specialized pharmaceutical product, with a period of performance ending on November 22, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...